Publication Date: 2024-05-27
Practice Area: Antitrust
Industry: Manufacturing | Pharmaceuticals
Court: U.S. District Court of Delaware
Judge: District Judge Burke
Attorneys: For plaintiff: Dominick T. Gattuso, Heyman Enerio Gattuso & Hirzel LLP, Wilmington, DE; W. Gordon Dobie, Winston & Strawn LLP, Chicago, IL; Susannah P. Torpey, Winston & Strawn LLP, New York, NY; Robert A. Julian, Baker & Hostetler LLP, San Francisco, CA for plaintiffs.
for defendant: Gary W. Lipkin, Michelle C. Streifthau-Livizos, Saul Ewing LLP, Wilmington, DE; Charles O. Monk, II, Jordan D. Rosenfeld, Saul Ewing LLP, Baltimore, MD; Jeffrey S. Robbins, Saul Ewing LLP, Boston, MA; Michael F. Brockmeyer, David S. Shotlander, Haug Partners LLP, Washington, D.C.; Ralph E. Labaton, Aakruti G. Vakharia, Haug Partners LLP, New York, NY; Daniel M. Silver, Alexandra M. Joyce, McCarter & English, LLP, Wilmington, DE; Erick J. Stock, Shireen Barday, Joshua Obear, Gibson Dunn & Crutcher LLP, New York, NY; Beth Moskow-Schnoll, Tyler B. Burns, Ballard Spahr LLP, Wilmington, DE; Adam K. Levin, Benjamin Holt, Ilana Kattan, Kaitlyn Golden, Hogan Lovells US LLP, Washington, D.C. for defendants.
Case Number: 22-1302-CJB
Plaintiffs adequately pled antitrust claims by alleging various anticompetitive acts by defendants designed to prevent or delay market entry of competing products, which resulted in the failure of plaintiffs' product launch.